ID   C1R-A33
AC   CVCL_C0RA
DR   Wikidata; Q112929351
RX   PubMed=14871991;
CC   Population: Caucasian.
CC   Transfected with: HGNC; 4931; HLA-A (allele A*33:03).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=14871991; DOI=10.1158/1078-0432.CCR-0797-3;
RA   Takedatsu H., Shichijo S., Katagiri K., Sawamizu H., Sata M., Itoh K.;
RT   "Identification of peptide vaccine candidates sharing among HLA-A3+,
RT   -A11+, -A31+, and -A33+ cancer patients.";
RL   Clin. Cancer Res. 10:1112-1120(2004).
//